In experiments similar to those using CCh, we have been unable to demonstrate significant effects of glucose (20 mM) on PKC translocation at times (2-10 min) when this concentration of glucose stimulated insulin secretion [8] and the production de novo of DA [14]. PKC is a family of isoenzymes which may have differing sensitivities to different activators [3] . It is conceivable that glucose activates only a minority subspecies of PKC whose translocation is not detectable in an assay which measures activity of all PKC isoenzymes, or that glucose activates an isoenzyme which does not translocate to membranes upon activation. An alternative explanation is that the DAG generated in response to glucose does not activate PKC, perhaps because of its cellular localization, and that the translocation of PKC is not obligatory for glucose-induced insulin secretion.
In experiments similar to those using CCh, we have been unable to demonstrate significant effects of glucose (20 mM) on PKC translocation at times (2-10 min) when this concentration of glucose stimulated insulin secretion [8] and the production de novo of DA [14] . PKC is a family of isoenzymes which may have differing sensitivities to different activators [3] . It is conceivable that glucose activates only a minority subspecies of PKC whose translocation is not detectable in an assay which measures activity of all PKC isoenzymes, or that glucose activates an isoenzyme which does not translocate to membranes upon activation. An alternative explanation is that the DAG generated in response to glucose does not activate PKC, perhaps because of its cellular localization, and that the translocation of PKC is not obligatory for glucose-induced insulin secretion.
In conclusion, our studies using isolated islets of Langerhans in which PKC activity has been down-regulated by phorbol ester treatment suggest that PKC may not be an important mediator of glucose-induced insulin secretion, but suggest a role for PKC in the transduction of cholinergic stimulation of insulin secretion. These conclusions are supported by direct measurements of the translocation of PKC activity from cytosol to membranes in response to a cholinergic agonist.
In 1984 we emphasized [ l ] the criteria that had to be satisfied in order to implicate protein phosphorylation in regulation of insulin secretion or biosynthesis: (1) the presence in the pancreatic B-cell of the particular protein kinase must be established; ( 2 ) both endogenous substrate( s) and appropriate phosphatase(s) must be shown to be present; (3) changes in phosphorylation of a particular endogenous substratejs) should occur in parallel with changes in insulin secretion or biosynthesis in the intact cell; (4) the nature and role of the endogenous substrates should be established and the functional consequences of phosphorylation demonstrated. These criteria are still far from being satisfied for either biosynthesis or secretion of insulin. This may be attributed to our incomplete knowledge of the biomolecules involved in these processes. We review here some aspects of the current understanding of the relevance of protein phosphorylation to B-cell function.
Role of protein kinase A in the pancreatic B-cell
Protein kinase A has been detected and characterized in various B-cell preparations as reviewed in [l] . Type I and type I1 isoenzymes have been demonstrated in rat islets with properties similar to those found in other tissues [2] . Substrates for protein kinase A have been studied in intact islets It is well established that an increase in B-cell cyclic AMP magnifies the secretory response to an initiator of secretion such as glucose (reviewed in [6] ). This potentiation of insulin secretion is accompanied by rapid phosphorylation of specific islet substrates for protein kinase A [3] , supporting a modulatory role for protein kinase A in the regulation of insulin secretion.
Early studies produced conflicting findings on a possible role of cyclic AMP in modulating insulin biosynthesis [7, 81 ; more recent studies, however, have provided evidence for a role for cyclic AMP in transcriptional regulation of the insulin gene. Northern-blot analysis demonstrated in both HIT T 1 5 B-cells [9] and human islets of Langerhans [lo] that forskolin elicited a significant potentiation of the stimulatory effect of glucose on preproinsulin mRNA levels.
Role of protein kinase C in the pancreatic R-cell
Protein kinase C has been purified to homogeneity from HIT T 15 B-cells and its kinetic properties determined [ 111.
As in other tissues, the enzyme appears as a monomeric species of about 80 kDa. There is no information yet as to which isoenzyme is present in the B-cell. Endogenous substrates for protein kinase C have been demonstrated in extracts of rat [ 11 or mouse [ 121 islets, in rat insulinoma [ 131, in permeabilized islets [5] and in intact islets [ 141 in which the main substrate was found to be a 24000 g particulatefraction protein of 37 kDa.
Evidence for involvement of protein kinase C in insulin secretion has been sought by seeking parallels between the effects of various agents on activity of the enzyme and on insulin release. Tumour-promoting phorbol esters such as 12-0-tetradecanoyl phorbol 13-acetate (TPA), which activate protein kinase C by substituting for diacylglycerol, are potent potentiators of insulin release (for review see [ l , 151) and this effect has been shown to be accompanied by enhanced phosphorylation of islet proteins [14] . The nonsteroidal anti-oestrogen clomiphene is a potent inhibitor of protein kinase C and blocked effects of TPA on insulin release and protein phosphorylation in intact islets [ 141. The protein kinase C inhibitor H-7 also blocks TPA-stimulated insulin release [ 151.
A key question is whether protein kinase C is involved in the insulin secretory response to glucose or whether its role is confined to those agents acting via enhanced breakdown of phosphatidylinositol bisphosphate and consequent generation of diacylglycerol. The very modest effect of clomiphene on glucose-induced insulin release [ 141 suggests that protein kinase C does not play a major role in glucose-induced secretion. A similar conclusion was reached from studies of islets cultured in the presence of TPA to down-regulate protein kinase C; in such islets a secretory response to glucose was still obtained although the potentiatory effect of TPA was lost [ 161. We have performed similar studies on HIT cells (S. J. Hughes, unpublished work); down-regulated HIT cells retained secretory responses to glucose, but the responses to TPA or cholinergic agents were abolished. These studies suggest that the main role of protein kinase C is in the modulation of insulin secretion by cholinergic agents.
Protein kinase C may also modulate insulin biosynthesis. In HIT cells, TPA caused a marked increase in levels of preproinsulin mRNA 191. In human islets, however, TPA inhibited by 50% the increase in preproinsulin mRNA evoked by glucose, despite inducing a 2-fold potentiation of insulin release [lo]. Furthermore, bradykinin, which may activate protein kinase C indirectly via phosphoinositide turnover, inhibited glucose-stimulated preproinsulin mRNA in human islets without affecting insulin secretion [lo] . . The latter is more attractive as a possible component of the secretory system in view of the possibility that the motile force for granule movement could arise from interaction of actin and myosin. MLCK has been partially purified from rat insulinoma [ 171; its presence has also been demonstrated in rat islets [ 181 and we have shown that it is also in human islets [ 11. We have located unequivocally MLCK to the B-cell by showing its presence in HIT cells [ 11.
Role of Ca
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We have shown that rat islets also contain a CaZ+-calmodulin-dependent protein kinase (P53 kinase) that phosphorylates an endogenous protein of 53 kDa as shown by SDS/gel electrophoresis. Properties of the kinase have been documented in detail [ 191 and the activity has been reported in various insulin-secreting tissues including human islets of Langerhans [20] . Since the kinase activity has not been separated from the phosphorylated peptide, it is likely that the observed phosphorylation represents an autophosphorylation. Phosphorylation is stimulated by micromolar concentrations of Ca2+ in the presence of calmodulin and is blocked by calmodulin antagonists. Our own [ l , 191 and other [21] studies have led to the conclusion that the kinase is a component of the B-cell cytoskeleton and a role in mediating granule-cytoskeleton interaction seems plausible.
Several pro erties of P53 kinase are reminiscent of multifunctional CaF+ -calmodulin-dependent protein kinase [ 2 2 ] , but this identity has not been established. In recent preliminary studies (S. J. H. Ashcroft, unpublished work) we did not find any effect of dehydrouramil (DHU) or alloxan, at concentrations which markedly inhibit P53 kinase (see below), on authentic multifunctional Ca? + -calmodulin-dependent protein kinase (kindly provided by Dr G . Hardie) .
There is little direct evidence to implicate MLCK in insulin secretion; although increased phosphorylation of a 20 kDa protein was observed in HIT cells incubated with depolarizing concentrations of K + [23] , rigorous identification of MLCK has not been reported. However, pretreatment of islets with concentrations of alloxan that inhibit insulin secretion was shown to lead to inhibition of P53 kinase; alloxan also inhibited the kinase in islet homogenates [24] . We extended these observations to DHU, a stable analogue of alloxan [25] . DHU inhibited P53 kinase in extracts of islets with a half-maximal effect at 90 PM. DHU did not inhibit protein kinase A and caused only minor inhibition of protein kinase C. In intact islets pre-exposure to DHU impaired the insulin-secretory response to glucose and blocked the potentiatory effects on insulin release of forskolin and TPA. These data suggest that P53 kinase may play a central role in the initiation of insulin release.
Protein phosphorylation and insulin secretion
There are two distinct mechanisms which can be envisaged by which protein kinase activation potentiates glucose-stimulated insulin release. Protein kinase activation may lead to an additional increase in intracellular Ca2+ via net influx of Ca2 + across the plasma membrane and/or efflux from intracellular compartmerts. Alternatively, protein kinase activation may sensitize the secretory mechanism to the existing level of intracellular Ca2 +.
Evidence from our laboratory favours the latter mechanism. In our earlier studies, we investigated the relationship between glucose-stimulated insulin release and extracellular Ca2+ in intact islets of Langerhans in the presence of drugs which activate B-cell protein kinases [26] . Our data showed clearly that activation of either protein kinase A or protein kinase C reduced the threshold extracellular CaL + concentration at which glucose-stimulated insulin release could take place and increased the maximal secretory response at the highest extracellular Ca2 + concentration. We suggested that this effect reflected an altered dose-response of insulin release to intracellular Ca2+. To substantiate this we went on to use HIT T15 B-cells to measure intracellular Ca2+ using Ca2+-binding fluorescent indicators [27, 281 . We first confirmed that, as in normal islets, the sensitivity to extracellular Ca2+ of glucose-stimulated insulin release from HIT cells was increased by protein kinase activation. In order to understand the events taking place inside the B-cell, we then incubated HIT cells in suspension and increased the extra-cellular Ca2+ concentration in a step-wise manner. In the presence of secretagogues which depolarize the plasma membrane, e.g. glucose or K + , we showed that intracellular Ca2+ levels increased in a dose-related manner in response to the stepwise increases in extracellular Ca2 +. The increases in intracellular Ca2+ at each step occurred over 2-3 min before reaching a new steady-state level. These data indicated that the intracellular Ca2+ concentration was dependent on both the extracellular Ca' + concentration and the potency of a given secretagogue to depolarize the plasma membrane. Furthermore, glucose-stimulated insulin release could only take place at extracellular Ca2+ concentrations which promote a substantial rise in intracellular Ca2+. We then assessed directly the effects of activators of protein kinases on the relationship beween extra-and intra-cellular Ca2 +. I t was argued that if potentiation involved increased flux of Ca2+ into the cytosol we would predict an increased cytosolic free Ca2+ level at a given extracellular Ca'+ concentration in the presence of a potentiator. Such an increase would not be expected if potentiation by activation of protein phosphorylation involved primarily a sensitization of the insulin secretion system to intracellular Ca2 + concentration of 1 mM was much greater than that found with glucose alone at an extracellular Ca'+ concentration of 2.5 mM; however, cytosolic free Ca? + concentrations were identical under these two conditions. Thirdly, TPA-potentiated insulin release at an extracellular Ca2 + concentration of 1 mM was similar to that from control cells at 2.5 mM extracellular Ca2+, despite the fact that the cytosolic free Ca2+ concentration was lower in the former condition. Indeed, TPA in general tended to lower intracellular Ca2+ concentrations somewhat. We concluded that stimulation of B-cell protein kinases primarily leads to potentiation of secretory responses by enhancing the sensitivity of the secretory mechanism to Ca2 + . This does not rule out the possibility of additional effects on B-cell Ca2+ fluxes. The observation that forskolin, for example, increased electrical activity of mouse islets depolarized by tolbutamide [29] is consistent with our findings of a modest rise in cytosolic free Ca2+ induced by forskolin [28] . The suggestion that protein kinase C activation may lead to Ca?+ influx [30] is not supported by our observations 1281 of a decrease in cytosolic free Ca2 + induced by TPA in HIT cells and the lack of effect of TPA on membrane electrical activity [3 11 . We suggest that the effects of potentiators on Ca2+ fluxes are of less importance than the ability of protein kinase activation to lead to an increased sensitivity to intracellular Ca2
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